ArticlePDF Available

Primary Intracranial Adenoid Cystic Carcinoma: A Case Report

Authors:

Abstract and Figures

Adenoid cystic carcinoma (ACC) is a rare slow-growing but aggressive malignant tumor arising from the epithelial cells of mucous-secreting glands. Primary intracranial ACC is one of the rarest entity. We report a case of a 61 years old male presenting with difficulty in swallowing, slurring of speech, generalized body weakness. Patient had residual right cerebellopontine angle (CPA) mass causing midline shift and fourth ventricular obstruction on MRI. Patient underwent right retrosigmoid craniotomy with excision of CPA mass. Histopathological examination confirmed the case as primary intracranial ACC.
Content may be subject to copyright.
JNMA I VOL 63 I ISSUE 282 I February 2025
117
Free Full Text Articles are Available at www.jnma.com.np
CASE REPORT J Nepal Med Assoc 2025;63(282):117-9
CC
BY
doi: 10.31729/jnma.8890
CC
BY
______________________________________
Correspondence: Dr. Pralisha Maharjan, Department of
Laboratory Medicine and Pathology, Nepal Mediciti Hospital,
Sainbu, Lalitpur, Nepal. Email: pralisha.mhzn@gmail.com,
Phone: +977-9849113661.
Primary Intracranial Adenoid Cystic Carcinoma: A Case Report
Pralisha Maharjan,1 Gopi Aryal,1 Reena Rana,1
1Department of Laboratory Medicine and Pathology, Nepal Mediciti Hospital, Lalitpur, Nepal.
ABSTRACT
Adenoid cystic carcinoma (ACC) is a rare slow-growing but aggressive malignant tumor arising
from the epithelial cells of mucous-secreting glands. Primary intracranial ACC is one of the rarest
entity. We report a case of a 61 years old male presenting with difculty in swallowing, slurring
of speech, generalized body weakness. Patient had residual right cerebellopontine angle (CPA)
mass causing midline shift and fourth ventricular obstruction on MRI. Patient underwent right
retrosigmoid craniotomy with excision of CPA mass. Histopathological examination conrmed the
case as primary intracranial ACC.
Keywords: adenoid cystic carcinoma; craniotomy; intracranial.
INTRODUCTION
Adenoid cystic carcinoma (ACC) is a rare slow-growing
but aggressive malignant tumor with potential of
perineural invasion. It accounts for less than 1% of all
head and neck malignancies and approximately 10%
of all salivary gland neoplasms. 1 Primary intracranial
ACC is one of the rarest entity. ACC has three main
histological patterns : solid, tubular, and cribriform.
Only eight cases of primary intracranial ACC have been
reported till date (1990-2022). 2,3 Here we report a case
of 61 years male diagnosed with primary intracranial
ACC.
CASE
A 61 years man presented with dysphagia, slurring of
speech, generalized body weakness for three months.
On clinical examination, he was conscious and
oriented, his vitals were stable and on other systemic
examinations no abnormalities were detected . On
neurological examination , higher motor function was
intact but patient had right sided lower motor neuron
facial palsy of grade III and right sided sensorineural
hearing loss, cerebellar signs were positive on right side
and had gait ataxia, gag reflex was absent and there
was no motor and sensory deficits. Hematological and
biochemical parameters were within normal limits. The
patient had significant past history of right CPA mass
for which he was operated at other medical center and
histological report was suggestive of neuroenteric
cyst. Repeated Magnetic Resonance Imaging (MRI)
showed tumor infiltrating the nerve sheath of cranial
nerves 9th , 10th and 12th on right side extending
into exocranial aspect and inferiorly along pterygoid
muscle, lateral wall of nasopharynx and right medial
temporal region for which intervention was not done.
Figure 1 A. Preoperative MRI brain revealing a
hyperintense lesion on T2-weighted image on
axial plane measuring 4.2 cm × 4.0cm × 1.4cm. B.
Postoperative MRI brain revealing heterogenous
collection at tumor resection bed in right lateral
aspect of posterior fossa where central component
of the collection displays mixed signal.
JNMA I VOL 63 I ISSUE 282 I February 2025
118
Free Full Text Articles are Available at www.jnma.com.np
Maharjan et al. Primary Intracranial Adenoid Cystic Carcinoma: A Case Report
The MRI done on 15th April, 2024 revealed right CPA
mass causing midline shift and fourth ventricular
obstruction (Figure 1). He underwent right retrosigmoid
craniotomy with excision of CPA mass on 23th April,
2024. Peroperatively, the lesion was greyish white to
greyish brown and firm.
On gross examination, the specimen appeared
greyish brown with largest nodular tissue measuring
1.5cmx1.2cm (Figure 2A). Cut sections showed solid
to cystic area. (Figure 2B). Remaining fragmented
tissue altogether measures 2.5x2.2cm. Entire tissue
submitted.
Figure 2. A. Gross image appeared greyish white to
greyish brown nodular tissue. B. Cut section showed
solid to cystic area.
Microscopic examination revealed tumor tissue
predominantly composed of cribriform growth
pattern with nest of tumor cells with discrete, rounded
punched out gland like spaces filled with eosinophilic
to basophilic material (Figure 3A). Area of tubular
pattern with multiple ducts and tubules like structure
are lined by small uniform cuboidal epithelium (Figure
3B). A focus of solid sheets of tumor cells (<30%
solid component) noted. Infiltrating tumor nests are
identified within fibrous stroma. Perineural invasion is
evident. Focal areas of reactive gliosis with dilated and
congested blood vessels are noted.
The tumor cells expressed CD117 positivity in luminal
layer and P40 and CK7 in myoepithelial layer but
was negative for S100 and Ki-67 was nearly 12%
(Figure 4). With all these histological features and
immunohistochemical reports, the case was finally
diagnosed as intracranial ACC.
To look for the primary site of the lesion, further
evaluation like chest X-ray, ultrasonography of
abdomen, and whole-body MRI was performed but
the primary site remained unknown so we concluded
the tumor to be intracranial in origin and diagnosed
it as primary intracranial ACC. Patient was managed
conservatively with intravenous antibiotics and all
other supportive measures. However, the patient
didn’t receive postoperative radiotherapy and he
passed away on 18th post operative day (POD).
Figure 3. A.Tumor tissue predominantly composed
of cribriform growth pattern with nest of tumor
cells with discrete, rounded punched out gland like
spaces filled with eosinophilic to basophilic material
(Hematoxylin and Eosin stain x10). B. Area of tubular
pattern with multiple ducts and tubules like structure
are lined by small uniform cuboidal epithelium
(Hematoxylin and Eosin stain x40).
Figure 3. A. The tumor cells expressed CD117
positivity in luminal layer. B and C.The tumor cells
expressed P40 and CK7 in myoepithelial layer. D. Ki-
67 was nearly 12%
DISCUSSION
ACC is a rare slow-growing but aggressive malignant
tumor. More than half of ACC arises from the minor
JNMA I VOL 63 I ISSUE 282 I February 2025
119
Free Full Text Articles are Available at www.jnma.com.np
Maharjan et al. Primary Intracranial Adenoid Cystic Carcinoma: A Case Report
salivary glands but it can also affect the major salivary
glands, paranasal sinuses, larynx, and trachea and
hard palate is most commonly affected intraoral
site.4 Though direct extension of the tumor or
invasion along cranial nerves is common but primary
intracranial ACC is extremely rare. Only eight cases of
primary intracranial ACC have been reported till date
(1990-2022) 2,3 where the youngest case was 34 years
and the eldest was 71 years, clinical features varied
from headache, epistaxis to hemianopia and left
facial region numbness and most common location
was cavernous sinus. Cases underwent operation,
radiosurgery and radiotherapy. Among them 3 cases
died after management while 2 cases were alive with
disease and 3 were alive without disease.
In our case, the mass was seen in right CPA causing
midline shift and fourth ventricular obstruction.
Literatures have shown that the tumors arising close
to the skull base may cause ocular dysmotility, and
cranial nerve (CN) palsies involving IX, X, XI, and XII.5,6
It is thought to arise from existing bucconasal cell
rests.7 Among the primary intracranial ACCs reported
in the literature, Gasserian ganglion, middle cranial
fossa, frontal lobe, cavernous sinus and posterior fossa
comprise majority of locations.8 Similar to findings
of these literatures, our case also had multiple nerve
sheath tumors (right IX CN, X CN, XII CN), extending
into exocranial aspect and inferiorly along pterygoid
muscle, lateral wall of nasopharynx and right medial
temporal region as seen on MRI.
Age of the patient, tumour site, clinical stage,
histological type with or without nerve involvement
are the important factors influencing prognosis
however the survival at 5,10, and 20 years around
68%, 52% and 28% respectively after decompression
surgery and postoperative radiotherapy.9The need
for early diagnosis and radical tumor resection, if
possible , coupled with postoperative radiation should
be emphasized so that local disease control and better
long-term survival will be achieved.10 However, the
patient didn’t receive postoperative radiotherapy and
he passed away on 18th POD .
Acknowledgement: I appreciate Dr. Shoshan
Raj Acharya, Dr. Arnav Singh Parmar for their
histopathological insights, and Mr. Ajay Shah for slide
preparations.
Consent: JNMA Case Report Consent Form was signed
by the patient.
Conflict of Interest: None.
REFERENCES
1. Chummun S, McLean NR, Kelly CG, Dawes PJ, Meikle D,
Fellows S et al. Adenoid cystic carcinoma of the head and
neck. Br J Plast Surg. 2001 Sep;54(6):476-80. [Full Text | DOI]
2. Sakata K, Ono T, Koga M, Kikuchi J, Komaki S, Akiba J,.
Primary Pituitary Adenoid Cystic Carcinoma: A Rare
Salivary Gland-Like Tumor in the Sella. Head Neck Pathol.
2021 Dec;15(4):1289-1298. doi: 10.1007/s12105-020-01256-7.
Epub 2021 Jan 4. [PubMed | Full Text]
3. Tsetsos N, Poutoglidis A, Terzakis D, Epitropou I, Oostra
A, Georgalas C. Primary Intracranial Adenoid Cystic
Carcinoma: Report of Three Cases. J Neurol Surg B Skull
Base. 2022 Jun 7;84(4):329-335. [PubMed | Full Text]
4. Lee RH, Wai KC, Chan JW, Ha PK, Kang H. Approaches to
the Management of Metastatic Adenoid Cystic Carcinoma.
Cancers (Basel). 2022 Nov 20;14(22):5698. [PubMed | Full
Text]
5. Tsuyuguchi N, Ohata K, Goto T, Haque M, Hara M.
Intracranial Adenoid Cystic Carcinoma of Suprasellar
Region. Acta Neurochir (Wien). 2001;143(7):729-32.
[PubMed | Full Text | DOI]
6. Ammad Ud Din M, Shaikh H. Adenoid Cystic Cancer.
2023 Apr 14. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing; 2024 Jan. [PubMed | Full Text]
7. Jayalakshmi S, Agarwal S, Nachiappan PL, Prasad
RR, Bhuthra S, Sharma MC et al. Intracranial Adenoid
Cystic Carcinoma--A Case Report. J Neurooncol. 2000
Mar;47(1):47-50. [PubMed | Full Text | DOI]
8. Huang M, Ma D, Sun K. Factors Inuencing Survival
Rate in Adenoid Cystic Carcinoma of the Salivary Glands.
Zhonghua Kou Qiang Yi Xue Za Zhi. 2000 Nov;35(6):430-3.
Chinese. [PubMed | Full Text | DOI]
9. Romani C, Lorini L, Bozzola A, Bignotti E, Tomasoni M,
Ardighieri L et al. Functional Proles of Curatively Treated
Adenoid Cystic Carcinoma Unveil Prognostic Features
and Potentially Targetable Pathways. Sci Rep. 2023 Jan
31;13(1):1809. [PubMed | Full Text]
10. Castelnuovo P, Turri-Zanoni M, Battaglia P, Antognoni P,
Bossi P, Locatelli D. Sinonasal Malignancies of Anterior
Skull Base: Histology-driven Treatment Strategies.
Otolaryngol Clin North Am. 2016 Feb;49(1):183-200. doi:
10.1016/j.otc.2015.09.012. PMID: 26614837. [PubMed | Full
Text | DOI]
© The Author(s) 2025.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article
are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this
license, visit https://creativecommons.org/licenses/by/4.0/
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Adenoid cystic carcinoma (ACC) of salivary gland is a slowly growing tumor showing a propensity for delayed recurrence, with decreased survival rates. The identification of poor prognosis patients may help in defining molecular-based targeted strategies in this rare disease orphan of new treatments. Through a gene expression microarray-based approach followed by GSE functional analysis the expression profile of 46 primary untreated ACC samples and of ACC (h-TERT) tumor cells was analyzed. Patients who experienced early relapse showed enrichment in proliferation-related gene sets, including the G2-M checkpoint, E2F and myc targets, and in gene sets related to IFN signaling and aberrant proteostasis (FDR < 0.1), indicating increased mitotic and transcriptional activity in aggressive ACC. Similar functions were enriched in ACC samples classified by immunohistochemical staining as p63-negative, which exhibited increased protein burden and activation of pro-survival stress response pathways compared to p63-positive tumors. Compared to ACC tissues, ACC (h-TERT) cells share transcriptional features of aggressive p63-negative tumors. These data suggest association of specific pathway alterations with histopathological features of ACC, as recapitulated by p63 testing in patient prognostic stratification, anticipating new avenues for therapeutic intervention.
Article
Full-text available
High rates of recurrence and distant metastasis are a foremost challenge in the management of adenoid cystic carcinoma (ACC), occurring in approximately 40% of all ACC patients. Despite the morbidity and mortality resulting from recurrent/metastatic (R/M) disease, there are no FDA-approved systemic agents for these patients. In this review, we summarize pertinent ACC pathophysiology and its implications for different systemic treatment regimens in R/M ACC. We review the evidence for the most widely used systemic agents — cytotoxic chemotherapy and tyrosine kinase inhibitors (TKIs) targeting VEGFR — in addition to immune checkpoint inhibitors and non-TKI biologic agents. Exciting emerging targets for R/M ACC, including inhibitors of Notch signaling, stemness, PRMT5, and Axl, are also discussed. Lastly, we review local therapies for small-volume lung disease in patients with oligometastatic ACC, specifically pulmonary metastasectomy and stereotactic body radiation therapy (SBRT). Future development of targeted molecular agents which exploit the underlying biology of this disease may yield novel therapeutic options to improve clinical outcomes in patients with R/M ACC.
Article
Ninety-one cases of adenoid cystic carcinoma (ACC) of the salivary glands with more than ten years' follow up were studied to investigate factors influencing the survival rate of patients, which vary according to site, histological type, clinical stage and nature of therapy. The data were statistically analysed for survival curves. Log rank tests were employed to assess the statistical significance of various groups. As a result, it may be concluded that tumour site, clinical stage and histological type are the important factors influencing the prognosis. ACC of the palate and parotid, early clinical stage, glandular/tubular histological type, and tumour without nerve involvement had the best prognosis. ACC in the submandibular gland, maxillary antrum and tongue, advanced clinical stage (stage III and IV), solid histological type, and tumour with nerve involvement had a poor prognosis.
Article
Adenoid cystic carcinoma (ACC) is a relatively common malignant neoplasm which occurs in the head and neck region, particularly in the salivary glands. It is a slow growing, locally aggressive neoplasm with a unique feature of perineural spread. Intracranial extension can occur by direct extension, hematogenous metastases or by perineural spread. However, the occurrence of primary intracranial ACC with no evidence of a primary, is rare, with only ten cases reported in reviewed English literature until now. One such case is presented here with brief review of literature. This patient showed a good response to treatment with surgery followed by post-operative radiotherapy and has remained disease free, 32 months after the completion of treatment.
Article
Adenoid cystic carcinoma (ACC) is a rare malignant tumour believed to arise from the epithelial cells of mucous-secreting glands. It is a slow-growing but aggressive tumour with a propensity for perineural invasion. A 10 year review of 45 patients (19 males and 26 females with a median age of 56 years) treated for ACC at a single institution between 1989 and 1999 was performed to analyse factors involved in treatment failure, local control, treatment-related morbidity and mortality. The data collected were treated for survival curves according to the Kaplan-Meier method and the log-rank test was used to assess the statistical significance of the various groups. The overall survivals at 3 years and 5 years were 71% and 65%, respectively, while the disease-free survivals at 3 years and 5 years were 73% and 63% respectively. Out of the 45 patients, only six had local recurrences, yielding an 87% locoregional freedom from relapse; 16 patients (35.6%) developed distant metastases, with the lung (8/16) being the commonest site. Patients treated for tumours of the nose and paranasal sinuses experienced more morbidity than those with tumours at other sites. Positive margins, perineural invasion and solid histology of ACC were associated with increased morbidity and treatment failure. Patients treated with combined therapy did better than those who underwent a single treatment modality.
Article
Adenoid cystic carcinoma (ACC) is a relatively common head and neck tumor which grows slowly but locally aggressive and prone to recurrence. ACC most commonly arises in the major and minor salivary glands. Some rare cases of intracranial ACC with an unknown primary site have been reported. The authors present the first case of primary intracranial ACC of the suprasellar region. A 34 year-old female presented with one month's duration of visual disturbance and galactorrhea. Magnetic resonance image (MRI) showed intra- and suprasellar mass mimicking a craniopharyngioma. There was no evidence of invasion from an extracranial site. The operative findings showed the mass existed under the arachnoid membrane and seemed to originate from the pituitary stalk. Pathological diagnosis was ACC. After the first operation, local recurrence and CSF dissemination to the lower clivus occurred within two months. Recurrence repeatedly treated by Gamma knife radiosurgery 10 times and 4 times by surgery during a 3 year follow-up period. But total removal of the tumor at the first operation along with radiosurgery may control the lesion and prevent further recurrence.
Primary Pituitary Adenoid Cystic Carcinoma: A Rare Salivary Gland-Like Tumor in the Sella
  • K Sakata
  • T Ono
  • M Koga
  • J Kikuchi
  • S Komaki
  • J Akiba
Sakata K, Ono T, Koga M, Kikuchi J, Komaki S, Akiba J,. Primary Pituitary Adenoid Cystic Carcinoma: A Rare Salivary Gland-Like Tumor in the Sella. Head Neck Pathol. 2021 Dec;15(4):1289-1298. doi: 10.1007/s12105-020-01256-7. Epub 2021 Jan 4. [PubMed | Full Text]
Primary Intracranial Adenoid Cystic Carcinoma: Report of Three Cases
  • N Tsetsos
  • A Poutoglidis
  • D Terzakis
  • I Epitropou
  • A Oostra
  • C Georgalas
Tsetsos N, Poutoglidis A, Terzakis D, Epitropou I, Oostra A, Georgalas C. Primary Intracranial Adenoid Cystic Carcinoma: Report of Three Cases. J Neurol Surg B Skull Base. 2022 Jun 7;84(4):329-335. [PubMed | Full Text]